Pruritus Therapeutics Market To Reach USD 19.10 Billion By 2027 | Top Key Players Allergan, Astellas Pharma, Bristol-Myers Squibb

Posted on
by

Pruritus Therapeutics Market To Reach USD 19.10 Billion By 2027 | Top Key Players Allergan, Astellas Pharma, Bristol-Myers Squibb
High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research funding scenario, and drug development pressure on pharmaceuticals due to upcoming patent expiries are key factors contributing to high CAGR of Pruritus Therapeutics during forecast period.

According to the current analysis of Reports and Data, the global Pruritus Therapeutics market was valued at USD 11.77 Billion in 2019 and is expected to reach USD 19.10 Billion by year 2027, at a CAGR of 6.2 percent. The study covers therapeutic agents for ‘Pruritus’ – an unpleasant sensation that stimulates desire to scratch the skin. Pruritus therapeutics are available in wide range of skin conditions and other underlying causes of pruritus. Recent emergence of TRP channels as a drug target for treatment of itching is a major disruptive finding in pruritus sector. In line with this, TRP channel antagonists, TRPM8 agonists are some of the emerging TRP channel modulation mechanisms that can be for could be used for pruritus treatment.

Rising prevalence of target diseases, unmet needs of pruritus patients pushing the drug development, significant focus of pharmaceutical companies on development of novel mechanisms based pruritus drugs,  upcoming patent expiry, availability of public as well private funds for research, and favorable regulatory scenario, are some of the key factors propelling market growth in the industry. However, associated side effects, and availability of advanced alternative treatment options such as photo therapy, are the major hindrance for market growth during 2019-2027.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1176

Key participants include

Allergan, Astellas Pharma, Bristol-Myers Squibb, Cipla, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi.

Further key findings from the report suggest

  • Pruritus Therapeutics market is growing at a CAGR of 1% in Asia Pacific followed by North America and Europe, with 6.1 % and 6.0% CAGR, respectively. High pruritus prevalence across the globe is the key factor to accelerate the market growth during forecast period across all regions.
  • As of 2019, Corticosteroids is the dominating pruritus therapeutics which holds 41.4% of the global market. European regional market is the chief revenue generating source for this product segment, followed by North America and Asia-Pacific regions.
  • Calcineurin Inhibitors is expected to be the fastest growing market segment during forecast period 2019-2027 with a CAGR of 6.9%. However, associated side effects and costs are major challenge for the market growth of this market segment.
  • Skin conditions disease type segment (that includes xerosis, dermatitis, psoriasis, scabies, burns & scars, insect bites and hives) . was valued at USD 7.60 billion and is expected reach USD 12.60 billion by 2027.
  • Asia Pacific is expected to account for the 24.3% of the global Pruritus therapeutics market. Developing nations such China, and India are likely to witness high growth
  • Associated side effects related to pruritus therapeutics and lack of awareness about pruritus is likely to hinder the market growth during the forecast period.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1176

For the purpose of this report, Reports and Data has segmented the Pruritus Therapeutics market on the basis of type, disease type, treatment type, end use, and region:

Type (Revenue, USD Million; 2017–2027)

  • Corticosteroids
  • Antihistamines
  • Local Anesthetics
  • Counterirritants
  • Immunosuppressant
  • Calcineurin Inhibitors
  • Others

Disease Type (Revenue, USD Million; 2017–2027)

  • Skin conditions
  • Atopic Dermatitis
  • Allergic Contact Dermatitis
  • Urticaria
  • Others
  • Internal diseases
  • Nerve disorders
  • Psychiatric diseases
  • Irritation and allergic reactions

Treatment Type (Revenue, USD Million; 2017–2027)

  • Itchy skin treatment
  • Corticosteroid creams and ointments
  • Other creams and ointments
  • Oral medications

End Use (Revenue, USD Million; 2017–2027)

  • Hospital
  • Clinic
  • Others

Country-wise regional analysis covers:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1176

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.  

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/pruritus-therapeutics-market